393 related articles for article (PubMed ID: 31270299)
21. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
[TBL] [Abstract][Full Text] [Related]
22. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
24. TSH regulation dynamics in central and extreme primary hypothyroidism.
Eisenberg MC; Santini F; Marsili A; Pinchera A; DiStefano JJ
Thyroid; 2010 Nov; 20(11):1215-28. PubMed ID: 21062194
[TBL] [Abstract][Full Text] [Related]
25. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.
Di Donna V; Santoro MG; de Waure C; Ricciato MP; Paragliola RM; Pontecorvi A; Corsello SM
Thyroid; 2014 Dec; 24(12):1759-64. PubMed ID: 25268754
[TBL] [Abstract][Full Text] [Related]
26. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
27. Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
Hennessey JV
Endocr Pract; 2023 Jul; 29(7):572-580. PubMed ID: 37419564
[TBL] [Abstract][Full Text] [Related]
28. [Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?].
Wawrzyn H; Hesch RD
Med Klin (Munich); 2000 Aug; 95(8):421-8. PubMed ID: 10985062
[TBL] [Abstract][Full Text] [Related]
29. Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy.
Gullo D; Latina A; Frasca F; Squatrito S; Belfiore A; Vigneri R
Clin Endocrinol (Oxf); 2017 Aug; 87(2):207-215. PubMed ID: 28398655
[TBL] [Abstract][Full Text] [Related]
30. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract][Full Text] [Related]
31. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
Price DE; O'Malley BP; Northover B; Rosenthal FD
Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
33. Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.
Mosaferi T; Tsai K; Sovich S; Wilhalme H; Kathuria-Prakash N; Praw SS; Drakaki A; Angell TE; Lechner MG
Thyroid; 2022 May; 32(5):496-504. PubMed ID: 35199588
[No Abstract] [Full Text] [Related]
34. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
[No Abstract] [Full Text] [Related]
36. Patient-Tailored Levothyroxine Dosage with Pharmacokinetic/Pharmacodynamic Modeling: A Novel Approach After Total Thyroidectomy.
Brun VH; Eriksen AH; Selseth R; Johansson K; Vik R; Davidsen B; Kaut M; Hellemo L
Thyroid; 2021 Sep; 31(9):1297-1304. PubMed ID: 33980057
[No Abstract] [Full Text] [Related]
37. Unusual malabsorption of levothyroxine.
Jauk B; Mikosch P; Gallowitsch HJ; Kresnik E; Molnar M; Gomez I; Lind P
Thyroid; 2000 Jan; 10(1):93-5. PubMed ID: 10691319
[TBL] [Abstract][Full Text] [Related]
38. Effects of Levothyroxine Replacement or Suppressive Therapy on Energy Expenditure and Body Composition.
Samuels MH; Kolobova I; Smeraglio A; Peters D; Purnell JQ; Schuff KG
Thyroid; 2016 Mar; 26(3):347-55. PubMed ID: 26700485
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K
Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335
[TBL] [Abstract][Full Text] [Related]
40. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
Xia Q; Dong S; Bian PD; Wang J; Li CJ
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
